Research graph
References from Methylphenidate treatment status and subclinical atherosclerosis in children and adolescents with ADHD: a cross-sectional comparative study. Local targets link to admitted publications; unresolved targets remain external evidence.
From subclinical atherosclerosis to plaque progression and acute coronary events: JACC state-of-the-art review
10.1016/j.jacc.2019.08.012 · 2019 · External reference
Evaluation of hematological inflammatory markers in children and adolescents with attention deficit/hyperactivity disorder
2021 · External reference
Evaluation of the relationship between cardiovascular risk factors and periaortic fat thickness in children with type 1 diabetes mellitus
10.1016/j.diabet.2015.02.005 · 2015 · External reference
Unresolved reference
2013 · External reference
A novel anti-inflammatory effect for high density lipoprotein
10.1371/journal.pone.0144372 · 2015 · External reference
Methylphenidate has positive hypocholesterolemic and hypotriglyceridemic effects: new data
10.1177/0091270009336736 · 2009 · External reference
Attention-deficit/hyperactivity disorder
10.1038/nrdp.2015.20 · 2015 · External reference
ADHD medications and risk of serious cardiovascular events in young and middle-aged adults
10.1001/jama.2011.1830 · 2011 · External reference
Long-term ADHD medications and cardiovascular disease risk
2023 · External reference
Seven psychiatric traits and the risk of increased carotid intima-media thickness: a Mendelian randomization study
10.3389/fcvm.2024.1383032 · 2024 · External reference
Epicardial adipose tissue: emerging physiological, pathophysiological and clinical features
10.1016/j.tem.2011.07.003 · 2011 · External reference
A cross-cohort study examining the associations of metabolomic profile and subclinical atherosclerosis in children and their parents: the child health CheckPoint study and Avon longitudinal study of parents and children
2019 · External reference
Conners parent rating scale-revised short: Turkish standardization study/Conners anababa dereceleme olcegi-yenilenmis kisa: Turkiye stardardizasyon calismasi
10.4274/npa.y6219 · 2013 · External reference
Novel hematologic ratios and systemic inflammation index in ADHD: effects of methylphenidate treatment
2025 · External reference
Schedule for affective disorders and schizophrenia for school-age children-present and lifetime version (K-SADS-PL): initial reliability and validity data
10.1097/00004583-199707000-00021 · 1997 · External reference
The revised Conners' parent rating scale (CPRS-R): factor structure, reliability, and criterion validity
10.1023/a:1022602400621 · 1998 · External reference
10.1016/j.echo.2005.10.005
10.1016/j.echo.2005.10.005 · 2005 · External reference
A review on the role of inflammation in attention-deficit/hyperactivity disorder
10.1159/000489635 · 2018 · External reference
Prediction of clinical cardiovascular events with carotid intima-media thickness: a systematic review and meta-analysis
10.1161/circulationaha.106.628875 · 2007 · External reference
Long-term safety of methylphenidate in children and adolescents with ADHD: 2-year outcomes of the attention deficit hyperactivity disorder drugs use chronic effects (ADDUCE) study
10.1016/s2215-0366(23)00042-1 · 2023 · External reference
Interaction between high-density lipoproteins and inflammation: function matters more than concentration!
10.1016/j.addr.2020.10.006 · 2020 · External reference
Reference values for weight, height, head circumference, and body mass index in Turkish children
10.4274/jcrpe.2183 · 2015 · External reference
Prevention of atherosclerosis from childhood
10.1038/s41569-021-00647-9 · 2022 · External reference
A review of the pathophysiology, etiology, and treatment of attention-deficit hyperactivity disorder (ADHD)
10.1177/1060028013510699 · 2014 · External reference
Cardiovascular safety of methylphenidate among children and young people with attention-deficit/hyperactivity disorder (ADHD): nationwide self controlled case series study
2016 · External reference
10.1159/000343145
10.1159/000343145 · 2012 · External reference
Reliability and validity of the schedule for affective disorders and schizophrenia for school-age children-present and lifetime version, DSM-5 November 2016-Turkish adaptation (K-SADS-PL-DSM-5-T)
2019 · External reference
Noninvasive assessment of subclinical atherosclerosis in children and adolescents: recommendations for standard assessment for clinical research: a scientific statement from the American Heart Association
10.1161/hypertensionaha.109.192639 · 2009 · External reference
Cardiovascular disease risk in children and adolescents with attention deficit/hyperactivity disorder
10.9758/cpn.2023.21.1.77 · 2023 · External reference
Risk of cardiovascular diseases associated with medications used in attention-deficit/hyperactivity disorder: a systematic review and meta-analysis
10.1001/jamanetworkopen.2022.43597 · 2022 · External reference
Attention-deficit/hyperactivity disorder medications and long-term risk of cardiovascular diseases
10.1001/jamapsychiatry.2023.4294 · 2024 · External reference
